View Report
September 02, 2025
Batch #ANZTRHD
Measured Result
1.05 mg
105.00% of label claim
Dragon Pharma
Dragon Pharma
Latest Laboratory Result
1.05 mg
September 02, 2025 · 105.00% of label claim
View
Arimidex 1 mg
Product Information
Compound Details
Active Substance
Anastrozole
Non-steroidal aromatase inhibitor
1 mg/tablet
Strength
1 mg/tablet
Package
100 Tablets
100 mg total labeled content
Form
Oral Tablet
Half-Life
Approximately 50 Hours
Drug Class
Aromatase Inhibitor
Manufacturer
Dragon Pharma
$66.00
Shipping :
International
U.S. Domestic
Buy 5+ for $61.38 and save $23.10
Product Overview
Arimidex 1 mg by Dragon Pharma
Arimidex 1 mg is an oral anastrozole tablet manufactured by Dragon Pharma and dosed at 1 mg per tablet in a 100-tablet package.
Anastrozole Oral
Arimidex 1 mg contains anastrozole, a non-steroidal aromatase inhibitor. Anastrozole works by blocking the aromatase enzyme, which converts androgens to estrogens. It is a triazole derivative that binds reversibly to the heme prosthetic group of aromatase, providing potent and specific inhibition of estrogen biosynthesis. In clinical practice, anastrozole is FDA-approved for the treatment of hormone receptor-positive breast cancer in postmenopausal women.
In non-medical bodybuilding contexts, Arimidex is commonly referenced as an aromatase inhibitor used to manage estrogenic side effects of anabolic steroid cycles, including gynecomastia, water retention, and elevated blood pressure. Illicit use by bodybuilders typically involves doses of 0.5 mg twice weekly starting from week two of a cycle. A forum analysis of aromatase inhibitor use in steroid users reported a mean anastrozole dose of 0.4 mg over a median of 70 days.
Anastrozole is a prescription medication, and its use for bodybuilding purposes is not approved by the FDA and is considered illegal. Medical supervision is required for any use of this compound, and self-medication carries significant risks including bone mineral density loss, arthralgia, dyslipidemia, and cardiovascular events.
Key Benefits of Arimidex 1 mg
- Potent and specific aromatase inhibition
- Half-life of approximately 50 hours supports less frequent dosing
- FDA-approved for hormone receptor-positive breast cancer
- Commonly referenced in bodybuilding for estrogen management
- 1 mg tablet strength for precise dosing
Product Profile
Anastrozole Profile
Anastrozole is a third-generation non-steroidal aromatase inhibitor characterized by potent and specific inhibition of estrogen biosynthesis, a long half-life of approximately 50 hours, and extensive hepatic metabolism.
Non-Steroidal Aromatase Inhibitor
Anastrozole belongs to the class of type II non-steroidal aromatase inhibitors. These agents are triazoles that bind reversibly to the aromatase enzyme, fitting into the substrate binding site so that azole nitrogens interact with the heme prosthetic group. This mechanism provides exquisite potency and specificity against aromatase, the enzyme responsible for converting androgens to estrogens.
The pharmacokinetics of anastrozole are well characterized. Plasma concentrations approach steady-state levels at about 7 days of once-daily dosing, and steady-state plasma levels are approximately 3- to 4-fold higher than levels observed after a single dose. The mean elimination half-life of anastrozole is approximately 50 hours. Anastrozole is 40% bound to plasma proteins in the therapeutic range.
Metabolism of anastrozole occurs by N-dealkylation, hydroxylation, and glucuronidation, with three metabolites identified in human plasma and urine. The major circulating metabolite, triazole, lacks pharmacologic activity. Hepatic metabolism accounts for approximately 85% of anastrozole elimination, while renal elimination accounts for approximately 10% of total clearance.
Defining Characteristic
Potent, Specific Aromatase Inhibition
Anastrozole provides potent and specific inhibition of the aromatase enzyme, with a half-life of approximately 50 hours that supports once-daily dosing in clinical settings.
Arimidex 1 mg vs Other Dragon Pharma Preparations
Dragon Pharma offers multiple ancillary compounds discussed in bodybuilding contexts. Anastrozole's aromatase inhibitor mechanism contrasts with selective estrogen receptor modulators such as Nolvadex (tamoxifen), which blocks estrogen receptors rather than inhibiting estrogen production. It is also distinct from Aromasin (exemestane), which is a steroidal aromatase inactivator that binds irreversibly to the enzyme.
The distinction between Arimidex and these compounds is primarily one of mechanism: anastrozole reversibly inhibits aromatase, while exemestane irreversibly inactivates it, and tamoxifen blocks estrogen receptors without affecting estrogen levels.
Laboratory Testing
Arimidex 1 mg Lab Reports
Published laboratory reports for Arimidex 1 mg are shown below with the test date, measured anastrozole content, and percentage of the product's 1 mg label claim.
View Report
View Report
June 17, 2024
Batch #ANZTRHD
Measured Result
1.19 mg
119.00% of label claim
Laboratory results apply to the specific tested sample represented in each published report and should not be interpreted as a measurement of every tablet or production batch.
Dosage & Usage
Arimidex 1 mg Dosage & Usage
The information below is provided for educational reference only. Anastrozole is a prescription medication approved for breast cancer treatment in postmenopausal women. Medical use requires appropriate diagnosis and clinical supervision. Non-medical use falls outside approved indications and is not recommended.
Typical Dosage Ranges
In medically supervised settings, the recommended dose of anastrozole is one 1 mg tablet taken once daily. In non-medical bodybuilding contexts, anastrozole is typically referenced at much lower doses, commonly 0.5 mg twice weekly starting from week two of an anabolic steroid cycle. A forum analysis reported a mean anastrozole dose of 0.4 mg over a median treatment duration of 70 days.
| Use Case | Common Reference Range | Frequency |
|---|---|---|
| Medical (breast cancer) | 1 mg / day | Once daily |
| Bodybuilding (non-medical) | 0.5 mg twice weekly | Starting week 2 of cycle |
| Forum-reported mean (non-medical) | 0.4 mg | Median 70 days |
Stacking & Cycle Considerations
In non-medical contexts, anastrozole is referenced alongside aromatizing anabolic steroids such as Testabol 400 or Dianabol 50 to manage estrogenic side effects. It may also be compared with Aromasin (exemestane), which is a steroidal aromatase inactivator. Dosing of anastrozole in this context should be based on individual response and bloodwork where possible.
Managing Side Effects
Anastrozole use can cause side effects including hot flashes, asthenia, arthritis, pain, arthralgia, pharyngitis, hypertension, depression, nausea and vomiting, rash, osteoporosis, fractures, back pain, insomnia, headache, peripheral edema, and lymphedema. Bone mineral density monitoring is recommended in patients treated with anastrozole due to observed decreases in lumbar spine and total hip BMD. Increased serum cholesterol has also been reported.
In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events was observed with anastrozole in the ATAC trial (17% of patients on anastrozole and 10% of patients on tamoxifen).
Important
Individual Response Varies
Anastrozole is a prescription medication. Non-medical use is not recommended and carries significant health risks. The information above is for educational reference and does not constitute medical advice.
Safety & Information
Anastrozole Safety Information
Anastrozole is a prescription medication that can affect bone mineral density, cholesterol levels, and cardiovascular health. Medical use requires appropriate diagnosis and clinical supervision.
Important Safety Information
Anastrozole is FDA-approved for adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, first-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor unknown locally advanced or metastatic breast cancer, and treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy.
Anastrozole is contraindicated in any patient who has shown a hypersensitivity reaction to the drug or to any of the excipients. Observed reactions include anaphylaxis, angioedema, and urticaria.
Important
Non-Medical Use
Anastrozole has no approved indication for bodybuilding or performance enhancement. Non-medical use falls outside approved indications and carries health risks including bone mineral density loss, arthralgia, dyslipidemia, and cardiovascular risk. Product strength and laboratory verification do not establish safety for non-medical use.
Potential Adverse Effects
Bone effects: Patients receiving anastrozole had a mean decrease in both lumbar spine and total hip bone mineral density compared to baseline in the ATAC trial. Bone mineral density monitoring is recommended.
Cardiovascular effects: In women with pre-existing ischemic heart disease, an increased incidence of ischemic cardiovascular events was observed with anastrozole (17% vs 10% on tamoxifen).
Cholesterol: More patients receiving anastrozole were reported to have elevated serum cholesterol compared to tamoxifen (9% vs 3.5%).
Common adverse reactions: Hot flashes, asthenia, arthritis, pain, arthralgia, pharyngitis, hypertension, depression, nausea and vomiting, rash, osteoporosis, fractures, back pain, insomnia, headache, peripheral edema, and lymphedema.
Embryo-fetal toxicity: Based on findings from animal studies and its mechanism of action, anastrozole can cause fetal harm when administered to a pregnant woman.
Conditions Requiring Medical Evaluation
Anastrozole should be used with caution in patients with pre-existing ischemic heart disease due to increased incidence of ischemic cardiovascular events. Bone mineral density monitoring is recommended. Pregnancy status should be verified prior to initiation of anastrozole in females of reproductive potential.
Monitoring During Therapy
Medically supervised anastrozole therapy involves monitoring for adverse effects including bone mineral density changes, cholesterol levels, and cardiovascular events. No dosage adjustment is necessary for patients with renal impairment or for elderly patients. No changes in dose are recommended for patients with mild-to-moderate hepatic impairment.
Product Care
Storage & Handling
Store in a cool, dry place away from direct light and moisture. Keep the product in its original packaging and out of the reach of children.
Further Safety Information
Shipping & Authenticity
Shipping & Product Authenticity
Arimidex 1 mg is supplied through the Dragon Pharma distribution chain and shipped in original manufacturer packaging with discreet, privacy-focused handling.
USA Domestic
3–5 business days
International
10–15 business days
Order Processing
24–48 business hours
Tracking
Provided after dispatch
Direct Supply
Discreet Delivery & Original Packaging
The outer shipping package remains discreet, with privacy-focused handling and no unnecessary external product details. Products are supplied through the Dragon Pharma distribution chain.
What to Expect
- Orders are processed after payment confirmation
- USA Domestic shipping is typically faster when local stock is selected
- International orders include tracking, though update frequency may vary by destination
- Multiple warehouses may result in separate shipments when applicable
Authenticity Verification
To verify your Arimidex 1 mg product, cross-check the security features on the packaging against Dragon Pharma's official presentation. Batch-linked lab proof and original packaging help reinforce product legitimacy.
For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.
Storage
Arimidex 1 mg Storage
Proper storage conditions help preserve tablet integrity and overall product stability throughout shelf life.
Recommended Conditions
Store in a cool, dry place away from excessive heat, moisture, and direct light. Maintaining stable conditions helps preserve the integrity of the tablets.
Keep the tablets in their original packaging until use. Do not use if the packaging appears compromised or if the tablets show signs of degradation such as discoloration or crumbling.
Keep out of reach of children.
Quick Reference
Do & Don't
- Do store in a cool, dry place
- Do keep in original packaging
- Do inspect tablets before use
- Don't expose to direct sunlight
- Don't store in humid environments
- Don't use if tablets appear abnormal
Frequently Asked Questions
Arimidex 1 mg FAQ
Answers to common questions about Arimidex 1 mg, anastrozole, aromatase inhibition, dosing, and safety.
What is Arimidex 1 mg used for?
Arimidex 1 mg contains anastrozole, a prescription aromatase inhibitor. It is FDA-approved for the treatment of hormone receptor-positive breast cancer in postmenopausal women. In non-medical bodybuilding contexts, it is referenced for managing estrogenic side effects of anabolic steroid cycles, though such use is not approved and is considered illegal.
How often should Arimidex 1 mg be taken?
In medical practice, the recommended dose is one 1 mg tablet taken once daily. In non-medical bodybuilding contexts, anastrozole is typically referenced at lower doses, commonly 0.5 mg twice weekly starting from week two of a cycle.
What does anastrozole do?
Anastrozole is a non-steroidal aromatase inhibitor. It blocks the aromatase enzyme, which converts androgens to estrogens, thereby reducing estrogen production. This mechanism is the basis for both its medical use in breast cancer and its non-medical use in bodybuilding for managing estrogenic side effects.
How long does Arimidex take to work?
Plasma concentrations of anastrozole approach steady-state levels at about 7 days of once-daily dosing. The half-life of anastrozole is approximately 50 hours, which supports once-daily dosing in clinical settings.
What is the half-life of anastrozole?
The mean elimination half-life of anastrozole is approximately 50 hours. Steady-state plasma levels are approximately 3- to 4-fold higher than levels observed after a single dose.
Is anastrozole the best aromatase inhibitor?
What is the difference between anastrozole and exemestane?
Anastrozole is a type II non-steroidal aromatase inhibitor that binds reversibly to the enzyme. Aromasin (exemestane) is a type I steroidal inactivator that binds irreversibly to the enzyme. Both reduce estrogen production but through different mechanisms.
What is the difference between anastrozole and tamoxifen?
Anastrozole is an aromatase inhibitor that reduces estrogen production. Nolvadex (tamoxifen) is a selective estrogen receptor modulator that blocks estrogen receptors without affecting estrogen levels. The two have different mechanisms and are not used in combination.
Is 1 mg of anastrozole a lot?
Medical anastrozole dosing is 1 mg per day for breast cancer treatment. In non-medical bodybuilding contexts, much lower doses are typically referenced, commonly 0.5 mg twice weekly. Arimidex 1 mg is labeled at 1 mg per tablet.
What strength is Arimidex 1 mg?
Arimidex 1 mg is labeled at 1 mg of anastrozole per tablet. It is supplied in a 100-tablet package, giving 100 mg of total labeled anastrozole content.
Is Arimidex 1 mg lab tested?
Yes. Published laboratory reports for Arimidex 1 mg are available. The most recent report dated September 02, 2025 measured the product at 1.05 mg per tablet, equivalent to 105.00% of its 1 mg label claim. Complete reports can be viewed in the Lab Reports tab.
Related Offers
Lab Tested
Domestic & International
Dragon Pharma, Europe
Product Information Compound Details
Active Substance Testosterone Cypionate Long-acting testosterone ester
250 mg/mLStrength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable (MCT Oil)
Estimated Half-Life Approximately 8 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
$53.00
Lab Tested
Domestic & International
Dragon Pharma, Europe
Product Information Compound Details
Active Substance Testosterone Enanthate Long-acting testosterone ester
250 mg/mLStrength 250 mg/mL
Package 10 mL Vial 2,500 mg total labeled content
Form Oil-Based Injectable (MCT Oil)
Estimated Half-Life Approximately 4.5–7 Days
Drug Class Androgen & Anabolic Steroid
Manufacturer Dragon Pharma
$46.00
Lab Tested
Domestic & International
Buy 5+ for $61.38 and save $23.10
Dragon Pharma, Europe
Product Information
Compound Details
Active Substance
Clomiphene Citrate
Selective Estrogen Receptor Modulator (SERM)
50 mg/tablet
Strength
50 mg/tablet
Package
100 Tablets
5,000 mg total labeled content
Form
Oral Tablet
Half-Life
5–7 Days (Enclomiphene)
Drug Class
SERM
Manufacturer
Dragon Pharma
$66.00
Lab Tested
Domestic & International
Buy 5+ for $46.50 and save $17.50
Dragon Pharma, Europe
Product Information Compound Details
Active Substance Tamoxifen Citrate Selective estrogen receptor modulator (SERM)
20 mg/tabletStrength 20 mg/tablet
Package 100 Tablets 2,000 mg total labeled content
Form Oral Tablet
Drug Class Selective Estrogen Receptor Modulator
Manufacturer Dragon Pharma
Half-Life Approximately 5–7 Days
$50.00